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ess: seferian.edward@mSummary Infants with cystic fibrosis (CF) may develop severe respiratory
compromise related to viral lower respiratory tract infections due to impaired
mucous clearance and plugging of small airways. Consequently air trapping may lead
to lung hyperinflation, impaired gas exchange, and respiratory failure. We describe
the case of an infant with newly diagnosed CF who developed severe hypercarbic
respiratory failure in the setting of viral bronchiolitis successfully treated with high-
frequency oscillatory ventilation (HFOV).
& 2005 Elsevier Ltd. All rights reserved.Introduction
Although not common, infants with cystic fibrosis
(CF) may develop severe respiratory failure due to
viral lower respiratory tract infections, such as
bronchiolitis, which can carry a high mortality.1,2
Both CF and bronchiolitis elicit physiological symp-
toms due to severe airflow obstruction in part dueElsevier Ltd. All rights reserve
f Pediatric Critical Care
dicine, 200 First Street,
l.: +1 507 255 7084; fax:
ayo.edu (E.G. Seferian).to mucus plugging of small airways. Moreover, in
this setting once respiratory failure necessitates
endotracheal intubation and mechanical ventila-
tion, mucus clearance is further hindered. Though
various means of chest percussion, postural drai-
nage and mucolytics have been utilized to enhance
airway clearance and reduce airway obstruction in
CF-related bronchiectasis, their role in infants with
CF and bronchiolitis is not established. While non-
invasive high-frequency oscillatory ventilation
(HFOV) has been used to enhance mucus clearance
for patients with CF,3 there are no reports of the
successful use of HFOV in the setting of severe
hypercapnic respiratory failure related to CF andd.
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effect of HFOV in the treatment of respiratory
syncytial virus (RSV) bronchiolitis associated hyper-
capnic respiratory failure in an infant newly
diagnosed with CF.Case
A 5-month-old male was admitted to the hospital in
August with cough and wheezing. Failure to grow
was noted (length, 40th %, weight, o3rd %). The
parents recalled some possible malabsorption of
formula. Physical exam was significant for dimin-
ished breath sounds with scattered wheezes
throughout all lung fields. Respiratory rate was
45/min and noted to be labored. Oxygen saturation
on room air was 85%. Continuous aerosolized
albuterol by facemask and supplemental oxygen
were administered. Within 24 h, the respiratory
distress increased necessitating endotracheal in-
tubation and mechanical ventilation (Siemens
Servo 300C, Mode ¼ pressure regulated volume
control, inspired oxygen fraction (FiO2) ¼ 0.45,
respiratory rate ¼ 32/min, tidal volume deliver-
ed ¼ 80ml, peak pressure ¼ 34 cmH2O, positive
end expiratory pressure (PEEP) ¼ 5 cmH2O) and
mean airway pressure (MAP) ¼ 8 cmH2O. Thick,
copious secretions were suctioned from the endo-
tracheal tube. Ventilation was initially acceptable
utilizing a hypercapnic strategy with an arterial
blood gas (ABG) following equilibration during
mechanical ventilation showing a pH of 7.18, PaCO2
of 80mmHg, and PaO2 of 91mmHg. RSV antigen was
detected by enzyme immunoassay. A culture of
airway secretions grew Pseudomonas aeruginosa,
and Enterobacter cloacae. Sweat chloride was
elevated at 88 and 87meq/l, 163 and 146mg,
respectively. Subsequent testing revealed the pre-
sence of N1303K and 3659del C gene mutations for
the cystic fibrosis transmembrane regulator (CFTR)
protein confirming the diagnosis of CF. Aerosolized
rHDNase was added to the regimen of intravenous
cefepime, gentamicin, and aerosolized tobramycin.
Despite the addition of systemic corticosteroids,
intravenous terbutaline, and helium–oxygen (70%
helium, 30% oxygen) delivered through the venti-
lator, the patient failed to improve. By the fourth
hospital day, respiratory acidosis worsened with an
ABG showing a pH of 7.18, PaCO24100mmHg, and
PaO2 of 83mmHg. Efforts to minimize dynamic
hyperinflation by reducing inspiratory time and
decreasing the respiratory rate to increase the
inspiratory/expiratory ratio did not improve venti-
lation nor prevent the development of tensionpneumothoraces requiring multiple chest tube
placements.
The patient continued to have poor ventilation
with repeated measurements of PaCO24100mmHg
(Fig. 1). Mechanical ventilation was changed to
HFOV (SensorMedics Oscillatory 3100A, Yorba Lin-
da, CA) FiO2 ¼ 0.35, frequency ¼ 7Hz, inspiratory
time % ¼ 30, DP ¼ 35 cmH2O, MAP ¼ 14 cmH2O.
Measurements of ventilation improved rapidly. As
shown in Fig. 1, PaCO2 declined significantly and
the patient had no further recurrences of severe
respiratory acidosis after the initiation of HFOV. In
addition, the air leak, which had been ongoing
during conventional mechanical ventilation (CMV),
resolved. There was no significant hemodynamic
compromise requiring intervention while on HFOV.
After 4 days of HFOV, the patient was placed back
on CMV for several days and successfully extubated.
The patient remained in the hospital to optimize
nutrition and was subsequently discharged home
without the need for supplemental oxygen. On
outpatient follow-up, the patient has had no
further severe respiratory exacerbations and is
thriving at this time.Discussion
This case demonstrates the potential utility of
HFOV in children with CF and severe hypercapnic
respiratory failure due to viral bronchiolitis. We
have shown an extended role of HFOV beyond the
usual use in children with hypoxic respiratory
failure. HFOV differs from CMV with regard to the
mechanism of gas exchange between inspired gases
and the alveoli. During HFOV, pressure oscillations
up to 900/min are generated in the proximal airway
which are associated with a constant, relatively
high MAP and significantly smaller tidal volumes
compared to CMV. Summation of gas exchange is
likely to occur through a combination of various
mechanisms including diffusion, Taylor dispersion,
Pendelluft mixing, asymmetric velocity profiles,
collateral ventilation, cardiogenic mixing and to a
lesser extent, bulk transport.4
The current treatment of severe bronchiolitis is
supportive care. Instillation of surfactant reduces
mechanical ventilation by an average of 2.6 days,
and ICU stay by 3.3 days, but immunoglobulin,
glucocorticoids, and heliox have no significant
effect.5 Though HFOV has been reported in the
management of refractory hypoxia in infants with
bronchiolitis,6 it is not generally recommended for
respiratory failure in association with significant
airflow obstruction because of the potential for
frequency-dependent worsening of dynamic hyper-
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Figure 1 Panels indicate PaCO2, pH, and PaO2/FiO2 during conventional mechanical ventilation (CMV) and high-
frequency oscillatory ventilation (HFOV).
E.G. Seferian et al.1468inflation.7 Dynamic lung hyperinflation can increase
the risk of barotrauma, dead space ventilation and
hemodynamic compromise from diminished return
of venous blood leading to low cardiac output.
Despite these potential adverse effects, the suc-
cessful use of high-frequency ventilation in respira-
tory failure with primarily obstructive pulmonary
physiology has been reported.8–11
In this case we postulate that pharmacologic
refractory random variations of mucus plugging and
impaired airway clearance contributed to the
observed stochastic severe elevations of PaCO2
(4100mmHg). We further postulated that HFOV,
like other forms of airway oscillatory therapy3
might improve mucus clearance and indirectly
reduce dynamic hyperinflation thereby improving
gas exchange. Our favorable result in this case is
consistent with reports in older children with
and without CF that have described the use of
non-invasive high-frequency oral and chest walloscillation to enhance mucus clearance in stable
outpatients,3,12 and in respiratory failure.13
A less commonly reported use of HFOV is the
management of refractory hypoxia in infants with
bronchiolitis.6 Parallel with the recent evidence of
improved outcomes in patients with acute respira-
tory distress syndrome (ARDS) who receive a low-
tidal volume, ‘‘open lung’’ strategy during CMV,14
there has been renewed interest in the use of HFOV
in adults. Analogously, in our case an increased and
constant MAP during HVOF compared to the MAP
during CMV may have elicited an ‘‘open airway’’
strategy by opening airways closed by high surface
tension. This latter mechanism may have reduced air
trapping and lung hyperinflation and enhanced
ventilation under these specific conditions. This
latter hypothesis is in accordance with a recent
report of a patient with status asthmaticus, where
during HFOV, PaCO2 was inversely related to in-
creases in MAP.8
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HFOV in an infant with CF and bronchiolitis 1469We recognize the possibility that the underlying
airway inflammation, infection and mucus produc-
tion may have been improving at the same time as
the implementation of HFOV and thus improve-
ments in pulmonary function were unrelated to the
change in ventilator management. However, this
seems unlikely given the magnitude and temporal
correlation, as well as the durability of the
improvement in ventilation after HFOV was in-
itiated. In conclusion, our experience suggests
promise for the use of HFOV in the management
of severe hypercapnic respiratory failure refractory
to CMV in infants with CF and viral bronchiolitis.References
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